JP2022527401A5 - - Google Patents
Info
- Publication number
- JP2022527401A5 JP2022527401A5 JP2021559994A JP2021559994A JP2022527401A5 JP 2022527401 A5 JP2022527401 A5 JP 2022527401A5 JP 2021559994 A JP2021559994 A JP 2021559994A JP 2021559994 A JP2021559994 A JP 2021559994A JP 2022527401 A5 JP2022527401 A5 JP 2022527401A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- compound
- administered
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962833140P | 2019-04-12 | 2019-04-12 | |
| US62/833,140 | 2019-04-12 | ||
| PCT/US2020/027981 WO2020210823A1 (en) | 2019-04-12 | 2020-04-13 | Compounds and methods for treating inflammatory disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022527401A JP2022527401A (ja) | 2022-06-01 |
| JP2022527401A5 true JP2022527401A5 (https=) | 2023-04-20 |
| JP7596296B2 JP7596296B2 (ja) | 2024-12-09 |
Family
ID=72751451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559994A Active JP7596296B2 (ja) | 2019-04-12 | 2020-04-13 | 炎症性障害を治療するための化合物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12398093B2 (https=) |
| EP (2) | EP3952851B1 (https=) |
| JP (1) | JP7596296B2 (https=) |
| KR (1) | KR20220008264A (https=) |
| CN (2) | CN113784709B (https=) |
| AU (1) | AU2020271915B2 (https=) |
| BR (1) | BR112021020424A2 (https=) |
| CA (1) | CA3136153A1 (https=) |
| WO (1) | WO2020210823A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL309842A (en) * | 2021-07-26 | 2024-02-01 | Univ Louisiana State | Compounds and methods for treating situations where the response depends on 5-HT2 |
| SE2151519A1 (en) | 2021-12-10 | 2023-06-11 | Amidea Sweden Ab | 2-(2,5-dimethoxyphenyl)ethanamine and uses thereof |
| WO2024010765A1 (en) * | 2022-07-05 | 2024-01-11 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compositions for treating 5-ht2 conditions and methods of using the same |
| WO2024191924A2 (en) * | 2023-03-10 | 2024-09-19 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compositions and methods of use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007016190A2 (en) * | 2005-07-28 | 2007-02-08 | Duke University | Antiparkinsonian action of phenylisopropylamines |
| US9642819B2 (en) * | 2008-07-10 | 2017-05-09 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical | Low dosage serotonin 5-HT2A receptor agonist to suppress inflammation |
| EP2884962B1 (en) * | 2012-08-17 | 2019-05-01 | Smartek International LLC | Preparation of desiccated liposomes for use in compressible delivery systems |
| US20200078335A1 (en) * | 2017-05-01 | 2020-03-12 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compositions and methods to reduce pathogenesis |
| GB201715919D0 (en) | 2017-09-29 | 2017-11-15 | Gw Res Ltd | use of cannabinoids in the treatment of epilepsy |
-
2020
- 2020-04-13 EP EP20788460.2A patent/EP3952851B1/en active Active
- 2020-04-13 US US17/603,091 patent/US12398093B2/en active Active
- 2020-04-13 CN CN202080030668.4A patent/CN113784709B/zh active Active
- 2020-04-13 BR BR112021020424A patent/BR112021020424A2/pt not_active Application Discontinuation
- 2020-04-13 EP EP25219576.3A patent/EP4685135A3/en active Pending
- 2020-04-13 JP JP2021559994A patent/JP7596296B2/ja active Active
- 2020-04-13 CN CN202410485765.2A patent/CN118384143A/zh active Pending
- 2020-04-13 WO PCT/US2020/027981 patent/WO2020210823A1/en not_active Ceased
- 2020-04-13 AU AU2020271915A patent/AU2020271915B2/en active Active
- 2020-04-13 KR KR1020217036157A patent/KR20220008264A/ko not_active Ceased
- 2020-04-13 CA CA3136153A patent/CA3136153A1/en active Pending
-
2025
- 2025-07-16 US US19/271,350 patent/US20260070872A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527401A5 (https=) | ||
| JP2023504415A5 (https=) | ||
| JP7498827B2 (ja) | 線維症治療剤 | |
| JP2016500111A5 (https=) | ||
| JP2023106403A5 (https=) | ||
| CN1701062A (zh) | 制备罗氟司特的新方法 | |
| JP2024516371A5 (https=) | ||
| JP6091593B2 (ja) | 慢性閉塞性肺疾患の急性増悪の治療におけるピラゾール誘導体の使用 | |
| JP2017526716A5 (https=) | ||
| JP2024170583A5 (https=) | ||
| JP2010515682A5 (https=) | ||
| CN118742310B (zh) | 一种次黄碱衍化合物在制备治疗肺纤维化药物中的应用 | |
| JP2019530674A5 (https=) | ||
| JP2022520990A (ja) | 呼吸器疾患の治療の方法 | |
| JP2006519824A5 (https=) | ||
| JP2025118775A5 (https=) | ||
| JP2024531188A5 (https=) | ||
| JP2016525573A5 (https=) | ||
| JP2023553253A5 (https=) | ||
| CZ111897A3 (cs) | Použití indolových derivátů pro výrobu léčiv a farmaceutický prostředek | |
| JP2022537964A5 (https=) | ||
| JP2013518061A5 (https=) | ||
| FI4199922T3 (fi) | (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa | |
| JP2023538419A5 (https=) | ||
| JP2023538125A5 (https=) |